Skip to main content

Table 1 Baseline characteristics of involved CAD patients and controls

From: A preliminary study showing no association between methylation levels of C3 gene promoter and the risk of CAD

Characteristics CAD (n = 100) Control (n = 100) P
Age, years 64.1 ± 10.9 63.1 ± 8.2 0.452
Male, n (%) 66 (66) 54 (54) 0.112
EH, n (%) 66 (66) 61 (61) 0.557
DM, n (%) 26 (26) 16 (16) 0.118
Smoking, n (%) 44 (44) 32 (32) 0.109
TC, mmol/l 4.70 ± 1.16 4.44 ± 0.81 0.064
TG, mmol/l 1.57 (1.06–2.40) 1.37 (0.96–2.11) 0.118
HDL-C, mmol/l 1.06 ± 0.23 1.20 ± 0.33 < 0.001
LDL-C, mmol/l 3.04 ± 0.98 2.71 ± 0.75 0.009
ApoAI, g/l 1.17 ± 0.20 1.31 ± 0.25 < 0.001
ApoB, g/l 1.00 ± 0.32 0.94 ± 0.22 0.081
  1. CAD coronary artery disease, EH essential hypertension, DM diabetes mellitus, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol